The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kallum Titchmarsh is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | PEN | Buy Now | Penumbra | $191.68 | 9.56% | $235 → $210 | Maintains | Equal-Weight | Get Alert |
| 07/15/2024 | INSP | Buy Now | Inspire Medical Systems | $138.58 | 51.54% | $250 → $210 | Maintains | Overweight | Get Alert |
| 03/19/2024 | INSP | Buy Now | Inspire Medical Systems | $138.58 | 80.4% | → $250 | Initiates | → Overweight | Get Alert |
| 11/03/2023 | PEN | Buy Now | Penumbra | $191.68 | 25.21% | $265 → $240 | Maintains | Equal-Weight | Get Alert |
| 09/06/2023 | PEN | Buy Now | Penumbra | $191.68 | 38.25% | → $265 | Initiates | → Equal-Weight | Get Alert |
